Jasmin L. Roder
Frankfurt Am Main, HE 60596, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Depletion of IL-10 in CAR-NK cells augments reprogramming of the tumor microenvironment and ameliorates therapeutic efficacy.
Journal: Molecular therapy. Oncology
Published: April 09, 2026
ErbB2/HER2-targeted CAR-NK cells eliminate breast cancer cells in an organoid model that recapitulates tumor progression.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 12, 2024
Co-Expression of an IL-15 Superagonist Facilitates Self-Enrichment of GD2-Targeted CAR-NK Cells and Mediates Potent Cell Killing in the Absence of IL-2.
Journal: Cancers
Published: June 26, 2023
Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma.
Journal: Neuro-oncology
Published: May 06, 2023
Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers.
Journal: Cancer immunology, immunotherapy : CII
Published: December 14, 2022
AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma.
Journal: Oncoimmunology
Published: October 17, 2022
Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity.
Journal: Journal for immunotherapy of cancer
Published: September 16, 2021
The Magnetic Electron Ion Spectrometer: A Review of On-Orbit Sensor Performance, Data, Operations, and Science.
Journal: Space science reviews
Published: August 31, 2020
A Revised Look at Relativistic Electrons in the Earth's Inner Radiation Zone and Slot Region.
Journal: Journal of geophysical research. Space physics
Published: November 29, 2018
3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids.
Journal: The EMBO journal
Published: October 16, 2018
Genetically engineered CAR NK cells display selective cytotoxicity against FLT3-positive B-ALL and inhibit in vivo leukemia growth.
Journal: International journal of cancer
Published: September 21, 2018
Last Updated: 09/26/2026